Yarrow Bioscience (YARW) Interest Expenses (2016 - 2025)
Yarrow Bioscience's (YARW) quarterly Interest Expenses came in at $2000.0 in Q2 2025, down 96.55% YoY from $58000.0 in Q2 2024, and down 98.41% on a QoQ basis from $126000.0 in Q4 2024.
Yarrow Bioscience (YARW) Interest Expenses (2016 - 2025) Analysis & Trends
Yarrow Bioscience (YARW) has 10 years of Interest Expenses data on file, last reported at $2000.0 in Q2 2025.
- Quarterly Interest Expenses fell 96.55% year-over-year to $2000.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $2000.0 (down 96.55% YoY) and the FY2025 annual result came in at $112000.0, down 99.89% from the prior year.
- Interest Expenses fell to $2000.0 in Q2 2025, from $126000.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $3.5 million in Q3 2021 to a low of -$3.2 million in Q4 2021.
- A 5-year average of $264857.1 and a median of $113000.0 in 2022 frame the typical range for Interest Expenses.
- The widest YoY moves for Interest Expenses: up 218.13% in 2021, down 321.8% in 2021.
- Tracing YARW's Interest Expenses over 5 years: stood at -$3.2 million in 2021, then surged by 103.1% to $100000.0 in 2022, then plunged by 35.0% to $65000.0 in 2023, then jumped by 93.85% to $126000.0 in 2024, then plunged by 98.41% to $2000.0 in 2025.
- The last three Interest Expenses figures came in at $2000.0 (Q2 2025), $126000.0 (Q4 2024), and $2000.0 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 82.05 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -4.89 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 20.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 93.62 Mn |
| 10 | Yarrow Bioscience | 31.25 Mn | 8.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 2,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Dec 31, 2024 | 126,000.00 |
| Dec 31, 2024 | 126,000.00 |
| Sep 30, 2024 | 2,000.00 |
| Sep 30, 2024 | 2,000.00 |
| Jun 30, 2024 | 58,000.00 |
| Jun 30, 2024 | 58,000.00 |
| Mar 31, 2024 | 70,000.00 |
| Mar 31, 2024 | 70,000.00 |
| Dec 31, 2023 | -49,000.00 |
| Dec 31, 2023 | -49,000.00 |
| Sep 30, 2023 | 300,000.00 |
| Sep 30, 2023 | 300,000.00 |
| Jun 30, 2023 | 300,000.00 |
| Jun 30, 2023 | 300,000.00 |
| Mar 31, 2023 | 300,000.00 |
| Mar 31, 2023 | 300,000.00 |
| Dec 31, 2021 | 3.23 Mn |
| Dec 31, 2021 | 3.23 Mn |